Masaya Sakamoto

2.3k total citations · 1 hit paper
55 papers, 1.8k citations indexed

About

Masaya Sakamoto is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Masaya Sakamoto has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Biology. Recurrent topics in Masaya Sakamoto's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (8 papers) and Cardiovascular Function and Risk Factors (6 papers). Masaya Sakamoto is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (8 papers) and Cardiovascular Function and Risk Factors (6 papers). Masaya Sakamoto collaborates with scholars based in Japan, United States and Australia. Masaya Sakamoto's co-authors include Yosuke Kayama, Kazunori Utsunomiya, Hirofumi Suzuki, Issei Komuro, Haruhiro Toko, Tohru Minamino, Yunzeng Zou, Norihiko Takeda, Philip S. Tsao and Uwe Raaz and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Masaya Sakamoto

51 papers receiving 1.7k citations

Hit Papers

Diabetic Cardiovascular Disease Induced by Oxidative Stress 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaya Sakamoto Japan 20 612 583 519 258 221 55 1.8k
Paulus Wohlfart Germany 23 665 1.1× 404 0.7× 377 0.7× 190 0.7× 577 2.6× 49 1.9k
Gisele Zapata‐Sudo Brazil 29 685 1.1× 413 0.7× 209 0.4× 284 1.1× 287 1.3× 107 2.1k
Doina Popov Romania 25 785 1.3× 364 0.6× 315 0.6× 189 0.7× 495 2.2× 65 2.1k
Romer A. González-Villalobos United States 28 813 1.3× 1.1k 1.8× 827 1.6× 133 0.5× 283 1.3× 46 2.3k
Ute Gödtel‐Armbrust Germany 21 512 0.8× 398 0.7× 226 0.4× 167 0.6× 366 1.7× 29 1.5k
Chunyu Zeng China 29 1.6k 2.6× 723 1.2× 532 1.0× 209 0.8× 351 1.6× 99 2.6k
Cheng Xue Qin Australia 27 977 1.6× 441 0.8× 194 0.4× 289 1.1× 372 1.7× 77 2.2k
Teresa Tejerina Spain 25 587 1.0× 373 0.6× 158 0.3× 257 1.0× 288 1.3× 85 1.6k
Giuseppe Rosano Italy 20 313 0.5× 549 0.9× 550 1.1× 268 1.0× 137 0.6× 39 1.5k
Tomohiro Osanai Japan 30 815 1.3× 1.2k 2.0× 296 0.6× 323 1.3× 562 2.5× 141 2.7k

Countries citing papers authored by Masaya Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Masaya Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Sakamoto more than expected).

Fields of papers citing papers by Masaya Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Sakamoto. The network helps show where Masaya Sakamoto may publish in the future.

Co-authorship network of co-authors of Masaya Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Sakamoto. A scholar is included among the top collaborators of Masaya Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Sakamoto. Masaya Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Masaya, et al.. (2025). Open Wireless Digital Twin: End-to-End 5G Mobility Emulation With OpenAirInterface and Ray Tracing. IEEE Access. 13. 175109–175122.
3.
Sakamoto, Masaya, et al.. (2020). A Consideration on Estimation of Lung Cancer Position using Tweezers-types of Electrodes at High Frequency bands. IEICE Technical Report; IEICE Tech. Rep.. 119(459). 109–112. 1 indexed citations
5.
Nakagama, Yu, Norihiko Takeda, Katsura Soma, et al.. (2019). Therapeutic targeting of mitochondrial ROS ameliorates murine model of volume overload cardiomyopathy. Journal of Pharmacological Sciences. 141(1). 56–63. 8 indexed citations
6.
Sakamoto, Masaya, Hirofumi Suzuki, Yosuke Kayama, et al.. (2018). Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report. Cardiovascular Diabetology. 17(1). 36–36. 39 indexed citations
7.
Sakamoto, Masaya. (2018). Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice. Journal of Clinical Medicine Research. 10(10). 737–742. 20 indexed citations
8.
Sakamoto, Masaya, et al.. (2017). Association between day-by-day and ambulatory blood pressure variability in type 2 diabetes patients. Blood Pressure Monitoring. 22(6). 351–354. 1 indexed citations
9.
Sakamoto, Masaya, Tomoo Itoh, Robert H. Tukey, & Ryoichi Fujiwara. (2015). Nicotine regulates the expression of UDP-glucuronosyltransferase (UGT) in humanized UGT1 mouse brain. Drug Metabolism and Pharmacokinetics. 30(4). 269–275. 11 indexed citations
10.
Sakamoto, Masaya, Hiroko Ushikubo, Hirofumi Michimae, et al.. (2015). Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain. Drug Metabolism and Disposition. 43(7). 1071–1076. 22 indexed citations
11.
Fujiwara, Ryoichi, et al.. (2014). UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Drug Metabolism and Pharmacokinetics. 30(1). 82–88. 18 indexed citations
12.
Suzuki, Hirofumi, Masaya Sakamoto, Takeshi Hayashi, et al.. (2013). Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report. Cardiovascular Diabetology. 12(1). 71–71. 10 indexed citations
13.
Kawanami, Daiji, et al.. (2012). Successful control of a case of severe insulin allergy with liraglutide. Journal of Diabetes Investigation. 4(1). 94–96. 10 indexed citations
14.
Sakamoto, Masaya, Hirofumi Suzuki, Takeshi Hayashi, et al.. (2012). Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure. Cardiovascular Diabetology. 11(1). 118–118. 8 indexed citations
15.
Kayama, Yosuke, Tohru Minamino, Haruhiro Toko, et al.. (2009). Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure. The Journal of Experimental Medicine. 206(7). 1565–1574. 128 indexed citations
16.
Miyazawa, Mitsuo, et al.. (2008). Use of Solid Phase Microextraction (SPME) for Profiling the Volatile Metabolites Produced by Glomerella cingulata. Journal of Oleo Science. 57(11). 585–590. 12 indexed citations
17.
Hoffmann, Jörg, et al.. (2007). Application of Rear Head Airbag to Mitigate Rear Impact Injuries. 20th International Technical Conference on the Enhanced Safety of Vehicles (ESV)National Highway Traffic Safety Administration. 1 indexed citations
18.
Zou, Yunzeng, Hiroyuki Takano, Miho Mizukami, et al.. (2003). Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction. Circulation. 108(6). 748–753. 99 indexed citations
19.
Homma, Tetsuya, et al.. (2000). Optical Properties of Fluorinated Silicon Oxide and Organic Spin-on-Glass Films for Thin-Film Optical Waveguides. Journal of The Electrochemical Society. 147(3). 1141–1141. 11 indexed citations
20.
Nakano, Shigeyuki, et al.. (1999). Factors Influencing Placebo Effects in Patients with Psychosomatic Disorders: Doctor-Patient Relationship, Patient's Motivation and Expectation for Drug Therapy.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 30(1). 1–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026